Discover the latest science based breakthroughs
in health, medicine and new drug approvals
New Hope for Alzheimer’s: Tackling Protein Clumps and Aging with Mitochondria Boosters
What did the research discover? This study explored how amyloid beta...
Videos
Drug Approvals
FDA Approves Fruzaqla: A New Hope for Metastatic Colorectal Cancer Patients, Approved November 8, 2023
What is Fruzaqla prescribed for? Fruzaqla is prescribed for the...
FDA Approves Loqtorzi for Advanced Nasopharyngeal Cancer on October 26, 2023
What is Loqtorzi prescribed for? Loqtorzi is prescribed to treat...
Latest Posts
FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023
What is XDEMVY prescribed for? XDEMVY is prescribed to...
FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023
What is Leqembi prescribed for? Leqembi is prescribed to...
FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024
What is Dupixent prescribed for? DUPIXENT (generic name: dupilumab),...
FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024
What is Amtagvi prescribed for? Amtagvi is prescribed to...
FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023
What is Elevidys prescribed for? To treat Duchenne...
FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023
What is BRENZAVVY prescribed for? BRENZAVVY is...
FDA Approves Xolair for Food Allergy Management on February 16, 2024
What is Xolair prescribed for? Xolair is prescribed to...
FDA Approves Exciting New Drug TRYVIO For High Blood Pressure on March 20, 2024
What is TRYVIO prescribed for? TRYVIO is a prescription...
FDA Approves NEXLETOL for High Cholesterol Management on March 22, 2024
What is NEXLETOL prescribed for? Nexletol is approved to...
FDA Approves LetsGetChecked Simple 2 Test for Chlamydia and Gonorrhea: November 15, 2023
What is LetsGetChecked Simple 2 Test prescribed for? The...
How FDA-Approved Doxycycline, Approved on June 6, 2024, is Helping with Rising STI Cases
What is Doxycycline prescribed for? Doxycycline is an...
New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024
What is it prescribed for? The Guardant Health Shield test is a...
New Liquid Medication Approved for ADHD Treatment: May 30, 2024
What is Onyda XR prescribed for? ONYDA XR (Clonidine...
FDA Approves First CRISPR Gene Therapy in January 2024 to Treat Beta-Thalassemia
What is Casgevy prescribed for? Casgevy is prescribed to...
Velsipity Approved for Moderate-to-Severe Ulcerative Colitis in Adults on October 13, 2023
What is Velsipity prescribed for? Velsipity is...
Zurzuvae approved for treatment of postpartum depression on August 04, 2023
What is Zurzuvae prescribed for? Zurzuvae is prescribed to treat...
Voquezna approved for Erosive Esophagitis and GERD by FDA on November, 2023
What is Voquezna prescribed for? Voquenza is indicated for the...
ScienceMyHealth delivers the latest updates on new drug approvals and groundbreaking medical research from the Food and Drug Administration, leading scientific journals, and top universities.
With new stories and videos posted daily, subscribers can stay informed and receive alerts to explore and find clinical trials relevant to their interests.
Trending News
FDA News Update: First Xarelto Generics Approved, New Testosterone Warnings, and Stroke Treatment Approval
For Immediate Release: March 04, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major...
FDA News Update: First Nicotine Pouches Receive Marketing Authorization Under Premarket Review
For Immediate Release: January 16, 2025 Today, the U.S. Food and Drug Administration authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application (PMTA) pathway following an extensive scientific review. This is the first...
FDA News Update: Food Safety, Medical Advances, and New Regulatory Actions
For Immediate Release: January 17, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA announced the release of a new prevention strategy aimed at combating the contamination of fresh and...
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
For Immediate Release: January 30, 2025 Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting...
FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials
For Immediate Release: January 06, 2025 Today, the U.S. Food and Drug Administration issued a draft guidance with the Office for Human Research Protections that, when finalized, will provide recommendations for including tissue biopsies as part of clinical trials.The...
FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions
For Immediate Release: January 06, 2025 Today, the U.S. Food and Drug Administration issued draft guidance to provide recommendations on the use of artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product’s safety,...
FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices
For Immediate Release: January 06, 2025 Today, the U.S. Food and Drug Administration issued draft guidance that includes recommendations to support development and marketing of safe and effective AI-enabled devices throughout the device’s Total Product Life Cycle. The...
FDA Roundup: December 27, 2024
For Immediate Release: December 27, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA announced recommended changes to labeling for transmucosal buprenorphine products indicated...